Medi Caps Ltd Share Price

49.05
(0.99%)
Jul 24, 2024|12:28:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open49.16
  • Day's High51
  • 52 Wk High63.49
  • Prev. Close48.57
  • Day's Low49
  • 52 Wk Low36.11
  • Turnover (lac)0.68
  • P/E15.57
  • Face Value10
  • Book Value53.31
  • EPS3.12
  • Mkt. Cap (Cr.)61.17
  • Div. Yield0
No Records Found

Medi Caps Ltd KEY RATIOS

Sector

Realty

Open

49.16

Prev. Close

48.57

Turnover(Lac.)

0.68

Day's High

51

Day's Low

49

52 Week's High

63.49

52 Week's Low

36.11

Book Value

53.31

Face Value

10

Mkt Cap (₹ Cr.)

61.17

P/E

15.57

EPS

3.12

Divi. Yield

0

Medi Caps Ltd Corporate Action

4 Sep 2023

12:00 AM

BookCloser

arrow

15 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

29 Aug 2023

12:00 AM

AGM

Announcement Date: 29 Aug, 2023

arrow

Medi Caps Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Medi Caps Ltd SHAREHOLDING SNAPSHOT

24 Jul, 2024|12:40 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 50.13%

Foreign: 0.00%

Indian: 50.13%

Non-Promoter- 0.02%

Institutions: 0.02%

Non-Institutions: 49.83%

Custodian: 0.00%

Share Price

Medi Caps Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

12.47

12.47

12.47

12.47

Preference Capital

0

0

0

0

Reserves

48.64

48.82

48.5

47.38

Net Worth

61.11

61.29

60.97

59.85

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

0

10.9

22.35

22.75

yoy growth (%)

-100

-51.19

-1.77

-9.1

Raw materials

0

-9.93

-10.17

-10.48

As % of sales

0

91.1

45.52

46.08

Employee costs

0

-5.88

-5.05

-5.08

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

0

-8.31

0.76

1.51

Depreciation

0

-0.35

-0.33

-0.36

Tax paid

0

0

-0.2

-0.35

Working capital

-0.91

-8.68

0.27

0.06

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-100

-51.19

-1.77

-9.1

Op profit growth

-100

-2,212.44

-42.27

-53.92

EBIT growth

-100

-1,188.04

-49.43

-13.32

Net profit growth

-98.66

-1,577.55

-51.29

-2.17

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

26.56

48.58

68.31

57.42

43.05

Excise Duty

0

0

0

0

0

Net Sales

26.56

48.58

68.31

57.42

43.05

Other Operating Income

0.78

0.79

1.56

1.3

2.27

Other Income

0.48

1.6

1.95

0.58

0.6

Medi Caps Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

DLF Ltd

DLF

809.7

166.262,00,425.99442.930.62909.41117.41

Godrej Properties Ltd

GODREJPROP

3,144.55

178.1687,436.4216.890659.9378.06

Prestige Estates Projects Ltd

PRESTIGE

1,761.55

287.3770,613.7866.70.1577.8170.49

Phoenix Mills Ltd

PHOENIXLTD

3,790.25

241.7367,741.2652.870.13115.6283.06

Oberoi Realty Ltd

OBEROIRLTY

1,688.55

38.2461,396.06459.280.241,173.97357.84

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Medi Caps Ltd

Management

Register Office

Registrar Office

Chairman (Non-Executive)

R C Mittal

Managing Director

Alok K Garg

Non-Exec. & Independent Dir.

Pramod Fatehpuria

Non-Exec. & Independent Dir.

Ashok Omprakash Agrawal

Non Executive Director

Kusum Mittal

Independent Director

Dharmendra Solanki

Company Sec. & Compli. Officer

Abhishek Kumar

Independent Director

Gajendra Singh

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Medi-caps was incorporated by S L Mittal in Aug.83 as a private limited company and was converted into a public limited company in Mar.86. Pharmaceutical companies procure empty hard gelatine capsules from Medi-caps for dosaged medicines meant for oral administration. The company is the second-largest manufacturer of empty hard gelatine capsules in India. It takes several years for a company manufacturing capsules to attain zero-defect in production and to fully normalise operations. Medi-caps can claim to have achieved this. In Apr.95, the company offered 6.11 lac rights shares at a premium of Rs 116 to part-finance the Rs 9.19-cr expansion of its manufacturing facilities (from 2000 mln pa to 3440 mln pa) by installing four high-speed automatic capsule-making machines.The companys manufacturing unit is located in Pithampur, Madhya Pradesh. The companys clientele include US Vitamins, SOL Pharmaceuticals, Dr Reddys Laboratories, Lupin Laboratories, Aristo Pharmaceuticals, etc. At present, it has 40 clients. The other group company of Medi-caps is Medi-caps Finance which is engaged in finance related activities. In 1993, R C Mittal received the Glory of India International award. In 1995-96, the company enhanced the capacity of empty hard gelatine capsules by 2500 lac. The company received ISO 9002 Certification during 1998-99. It developed six sizes of the Hard Gelatin Capsules in 2002-03. The company is closely working on commissioning of 13th Machine with 100% automisation.
Read More

Company FAQs

What is the Medi Caps Ltd share price today?

Down Arrow

The Medi Caps Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹49.05 today.

What is the Market Cap of Medi Caps Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Medi Caps Ltd is ₹61.17 Cr. as of 24 Jul ‘24

What is the PE and PB ratio of Medi Caps Ltd?

Down Arrow

The PE and PB ratios of Medi Caps Ltd is 15.57 and 0.91 as of 24 Jul ‘24

What is the 52 Week High and Low of Medi Caps Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Medi Caps Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Medi Caps Ltd is ₹36.11 and ₹63.49 as of 24 Jul ‘24

What is the CAGR of Medi Caps Ltd?

Down Arrow

Medi Caps Ltd's CAGR for 5 Years at 22.51%, 3 Years at 1.25%, 1 Year at 27.51%, 6 Month at -7.24%, 3 Month at -6.25% and 1 Month at -5.10%.

What is the shareholding pattern of Medi Caps Ltd?

Down Arrow

The shareholding pattern of Medi Caps Ltd is as follows:
Promoters - 50.13 %
Institutions - 0.03 %
Public - 49.84 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.